Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002132772 | SCV002433112 | likely benign | not provided | 2024-11-22 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002500185 | SCV002808141 | likely benign | McCune-Albright syndrome; Pseudohypoparathyroidism type 1C; Pseudohypoparathyroidism type 1B; Pseudopseudohypoparathyroidism; Progressive osseous heteroplasia; Pituitary adenoma 3, multiple types; ACTH-independent macronodular adrenal hyperplasia 1; Pseudohypoparathyroidism type I A | 2021-12-17 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV002132772 | SCV005210012 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV004531455 | SCV004755891 | likely benign | GNAS-related disorder | 2024-02-16 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |